Cargando…
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
SIMPLE SUMMARY: Oncolytic viruses can be a potent tool in the fight against cancer. However, in clinical settings their ability to replicate in and kill tumors is often limited. Combinations with specific small molecule compounds can address some of these limitations and help oncolytic viruses reach...
Autores principales: | Spiesschaert, Bart, Angerer, Katharina, Park, John, Wollmann, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306439/ https://www.ncbi.nlm.nih.gov/pubmed/34298601 http://dx.doi.org/10.3390/cancers13143386 |
Ejemplares similares
-
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
por: Das, Krishna, et al.
Publicado: (2021) -
Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP
por: Gautam, Saurabh, et al.
Publicado: (2022) -
Oncolytic Viruses: Therapeutics With an Identity Crisis
por: Breitbach, Caroline J., et al.
Publicado: (2016) -
Oncolytic viruses as therapeutic cancer vaccines
por: Bartlett, David L, et al.
Publicado: (2013) -
Targeted cancer treatment in silico: small molecule inhibitors and oncolytic viruses
por: Komarova, Natalia L, et al.
Publicado: (2014)